Oligonucleotides as Therapeutic Agents -

Oligonucleotides as Therapeutic Agents

Marvin Caruthers (Herausgeber)

Buch | Hardcover
260 Seiten
1997
John Wiley & Sons Ltd (Verlag)
978-0-471-97279-2 (ISBN)
144,45 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
A work that includes discussion of the chemistry of oligonucleotide analogues, and reports on structure activity studies and current clinical trials. The book draws on contributions from an interdisciplinary and international group of specialists concerned with research on the subject.
A work that includes discussion of the chemistry of oligonucleotide analogues, and reports on structure activity studies and current clinical trials, concluding with reviews of applications of ribozymes (RNA enzymes that catalyse RNA cleavage), of aptamers (oligonucleotides which bind specifically to proteins), and discussion of triplex-forming oligonucleotides. The book draws on contributions from an interdisciplinary and international group of specialists concerned with research on all aspects of the use of oligonucleotides as therapeutic agents. Coverage ranges from discussion of the basic chemistry of oligonucleotide synthesis through to the problems of drug delivery and mechanisms of action. It features data from ongoing clinical trials of these highly experimental agents.

Oligonucleotide analogues - an overview; phosphorothioate oligodeoxynucleotides - large scale synthesis and analysis, impurity characterization and the effects of phosphorous stereochemistry; discovering antisense reagents by hybridization of RNA to oligonucleotide arrays; pharmacokinetics of oligonucleotides in cell culture; pharmacokinetics of antisense oligonucleotides; cellular pharmacology of antisense oligodeoxynucleotides; sequence-specific control of gene expression by antigene and clamp oligonucleotides; differential oligonucleotide activity in cell culture versus mouse models; structure-activity relationships in cell culture; progress in antisense therapeutics; treating human myelogenous leukaemia with oligonucleotides targeted to the C-Myb gene - two years clinical experience; therapeutic applications of catalytic antisense RNA's; exogenous application of ribozymes for the inhibition of gene expression; SELEX derived drugs; in vivo production of oligonucleotide applications for antisense DNA.

Erscheint lt. Verlag 14.10.1997
Reihe/Serie Ciba Foundation Symposium ; No. 209
Zusatzinfo Ill.
Verlagsort Chichester
Sprache englisch
Maße 155 x 235 mm
Gewicht 540 g
Einbandart gebunden
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Naturwissenschaften Biologie Biochemie
Naturwissenschaften Biologie Zellbiologie
ISBN-10 0-471-97279-7 / 0471972797
ISBN-13 978-0-471-97279-2 / 9780471972792
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
36,00